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INTRODUCTION
Hypothyroidism is one of the most prevalent endocrine 
diseases. It can lead to a variety of clinical situations, 
including congestive heart failure, ileus, hypothermia, 
electrolyte disturbances and coma.1 Hyponatremia, on the 
other hand, is the most common electrolyte abnormality 
encountered in clinical practice.2 Herein, we report a case of 
myxedema coma with severe hyponatremia.
CASE HISTORY
A 78-year-old male was admitted to the emergency 
department for confusion. He had had a cerebrovascular 
event five years ago and had been using anti-hypertensive 
medication since then. His medications included 
acetylsalicylic acid 300 mg/day and lacidipine 4 mg/day. 
On physical examination, the patient was comatose and had 
a blood pressure of 90/60 mmHg, heart rate of 52 beats/min, 
respiratory rate of 18 breaths/min and temperature of 35.5 
°C. Systemic examination revealed coarse skin, hypoactive 
bowel sounds, decreased breath sounds and nonpitting 
pretibial edema. His laboratory findings were as follows: 
hemoglobin 11.6 g/dL, WBC 7400/mL, glucose 94 mg/
dL, urea 30 mg/dL, creatinine 0.5 mg/dL, calcium 8.4 mg/
dL, sodium 106 mmol/L, potassium 4.27 mmol/L, CRP 
13.6 mg/L, TSH 61.24 uIU/mL, and T4 <0.3 pmol/L. After 
the patient was diagnosed with severe hyponatremia, his 
medications were reevaluated; however, no anti-depressants, 
diuretics or other medications that can cause hyponatremia 
were reported. The patient’s urine osmolarity was 280 
mOsm/kg, and the urine sodium level was 96.02 mmol/L. A 
random cortisol level was detected as 17.6 ug/dL (reference 
range: 5-25 ug/dL). Arterial blood gas testing revealed a 
hypercarbia with pCO2 of 66.2 mmHg and pH of 7.33. No 
signs of an acute cerebrovascular event or cerebral edema 
were detected in brain computed tomography. Myxedema 
coma was diagnosed, and L-thyroxine sodium 500 μg was 
administered once orally and continued at a dose of 100 
μg/day by nasogastric tube. Isotonic saline was started at a 
rate of 100 mL/h. Hyponatremia recovered gradually with 
isotonic saline infusion and L-thyroxine therapy. On the fifth 
day of her hospitalization, the control serum sodium level 
was 134 mmol/L; the patient’s mental state was markedly 
improved, and the patient was discharged.
DISCUSSION
Myxedema coma is an uncommon but potentially 
lethal condition.2 It usually occurs in older patients with 
long-standing hypothyroidism. Classic manifestations of 
hypothyroidism include extreme bradycardia, hypotension 
and delayed relaxation of deep tendon reflexes.3 Myxedema 
coma was diagnosed in this case based on clinical and 
laboratory signs including altered mental status, decreased 
body temperature, very high TSH and low free T4.
Hyponatremia is frequently observed in hospitalized 
patients. It needs to be treated effectively, and the rate of 
correction should be adapted to the clinical situation. In 
our case, the serum sodium level increased gradually with 
L-thyroxine therapy and isotonic saline infusion. We believe 
that the coma was associated with both hyponatremia and 
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hypothyroidism in this patient. Although hypothyroidism is 
known to be a cause of hyponatremia, Kilpatrick et al. failed 
to identify a definite association between hypothyroidism 
and hyponatremia.4,5 Moreover, a case of life-threatening 
hyponatremia due to cessation of L-thyroxine treatment has 
been reported elsewhere.6 Because there was no etiological 
factor for hyponatremia apart from hypothyroidism in this 
case, we consider that the hypothyroidism caused this 
manifestation of hyponatremia.
The correct management of hyponatremia is extremely 
critical, not only in preventing complications but also in 
avoiding harm to the patient. A 4- to 6-mmol/L increase in 
serum sodium concentration corrects many neurological 
symptoms in the most seriously ill patients. Nevertheless, 
overcorrection of hyponatremia increases the risks of 
iatrogenic brain damage. In a recent review, the suggested 
therapeutic goals for correction rates are 6-8 mmol/L in 24 
hours, 12-14 mmol/L in 48 hours, and 14-16 mmol/L in 72 
hours.7 
In conclusion, severe hyponatremia can be a life-
threatening problem in clinical contexts and should be 
carefully managed. In light of this case, physicians should 
include hypothyroidism in the differential diagnosis of every 
patient with hyponatremia.
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